NAVVCB Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

IDIQ

Description

On behalf of the USDA APHIS Veterinary Services, provide Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), Storage of FMD VAC, Finishing of FMD VAC, and direct purchase of FMD Vaccine in support of the National Animal Vaccine and Veterinary Countermeasures Bank (NAVVCB).

Overview

Ceiling

$500,000,000

Primary Sponsoring Agency

Marketing and Regulatory Programs Business Services (MRPBS) [USDA - APHIS]

Who Can Use

One Agency

Primary NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Primary PSC

6505 - Drugs And Biologicals

Primary Set Aside

None

Extent Competed

Full And Open Competition

Related Opportunity

FMD VAC and Related Items for NAVVCB (12639520R0009)

NAVVCB Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC) awarded by Marketing and Regulatory Programs Business Services (MRPBS) in July 2020 accepts orders through January 2036. The IDIQ has a reported ceiling of $500,000,000, and as of today, $80,599,999 has been obligated through the vehicle. The IDIQ was awarded full & open and has a primary NAICS code of 325414.

Award Hierarchy

Vehicle

NAVVCB Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Indefinite Delivery Vehicles

Prime Contracts

Subcontracts

Status

Period of Performance

7/8/20

Start Date

1/7/36

Ordering Period End Date

33.0% Complete

Task Order Obligations

$80.6M

Total Obligated

$80.6M

Current Award

$80.6M

Potential Award

100% Funded

Vehicle Award Share

Contractors with greatest percentage of obligations for NAVVCB Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Vehicle Award Share

Federal Award Analysis